Bassagel

Eczema care is evolving. New treatments for chronic hand eczema and atopic dermatitis are continuing to emerge, with experts noting the need for more options - especially when thick skin, irritation, allergies, pain, and quality-of-life impact make treatment more complex.

At the same time, more prescribers are exploring customized topical approaches for appropriate patients, including compounded preparations that pair BASSAGEL with a prescriber-selected corticosteroid, antihistamine, or other medication.

BASSAGEL offers a water-washable ointment base designed to support topical application, and pharmacies often provide options that may include corticosteroids, antihistamines, antifungals, antibacterials, antivirals, and other medications based on the prescription and patient need.

For eczema patients who need something beyond the standard “one-size-fits-all” topical approach, a compounded option may be worth discussing.

Prescribers: Check out https://bassagel.com/compounded-medications-containing-bassagel/ to find pharmacies nationwide who work with BASSAGEL!

Compounded medications are not reviewed by the FDA for safety or efficacy.



https://www.dermatologytimes.com/view/chronic-hand-eczema-treatment-gaps-new-options-and-clinical-trial-end-points

Chronic Hand Eczema: Treatment Gaps, New Options, and Clinical Trial End Points | Dermatology Times At RAD 2026, David Rosmarin, MD, discussed the unmet need in chronic hand eczema, emerging pipeline agents, and his approach to evaluating clinical trial data.

Clear healthcare communication matters.

The FDA has reminded telehealth companies to avoid false or misleading claims when promoting compounded medications, including claims that these medications are FDA-approved, “generic,” or the same as an FDA-approved drug.

Patients deserve accurate information so they can make informed decisions with their licensed healthcare providers. This goes for any compounded medications - not just GLP-1s that likely triggered this communication.

FDA to Telehealth Companies FDA is concerned about telehealth companies promoting compounded drugs, including glucagon-like peptide-1 receptor agonists (GLP-1s) and other drugs, with false or misleading claims.

June is Wound Care Awareness Month — a reminder that proper wound care starts early.

Small wounds can become bigger problems when they are ignored. Whether you are dealing with dry, irritated skin, minor skin breakdown, or a wound-care routine recommended by your healthcare provider, keeping the area clean, protected, and cared for matters.

BASSAGEL™ is a water-washable, pharmacist-designed moisturizing ointment that can be used as part of skin and wound-care support. Its gentle, washable formula makes application and removal easier, helping support comfort and consistency in daily care.

This month, take a moment to check in on your skin health. If a wound is not healing, is getting worse, or shows signs of infection, seek medical attention early. Timely assessment and proper treatment can help prevent complications and support better healing.

Healthy healing starts with awareness.



https://kfdm.com/news/guests/wound-care-awareness-month-promoting-early-intervention-for-better-healing

Kingdom Investment Holdings

Wound Care Awareness Month: Promoting early intervention for better healing June is Wound Care Awareness Month highlighting the importance of timely wound assessment, proper treatment, and patient education in preventing complications a

A recent Men’s Health article spotlighted nutrients often discussed in connection with hair and scalp health, including biotin, zinc, omega-rich ingredients, vitamin C, vitamin E, vitamin A, and protein-derived building blocks.

At BASSAGEL, we’re exploring how topical delivery technology may help formulators work with a variety of actives like these in next-generation scalp and hair-care applications.

BASSAGEL is being assessed as a versatile platform for delivering targeted ingredients topically, supporting innovation in formulations designed for healthy-looking hair and scalp care.

Because when it comes to personal care, the future is not just about what actives you choose — it’s also about how you deliver them.

15 Foods That Will Give You Stronger, Thicker Hair If You’re Starting to Bald Dietitians and hair loss experts find these nutrient-dense foods key for stimulating hair growth.

Eczema flares can be frustrating — itching, redness, dryness, scaling, and irritated patches can make skin feel uncomfortable fast.

BASSAGEL® may be used as a topical base on its own, but it can also be part of a customized treatment plan when a prescriber orders medication capsules to be mixed directly into BASSAGEL® before application.

In many cases, a patient may receive a prescription capsule containing a medication powder intended for topical use. The capsule is opened, mixed with the directed amount of BASSAGEL®, and then applied to the affected area exactly as prescribed.

This approach may allow prescribers to personalize therapy for different eczema-related concerns, such as:

✅ Itching
✅ Irritation
✅ Inflammation
✅ Dry or thickened patches
✅ Areas that may benefit from localized topical treatment

BASSAGEL® is designed to offer an ointment-like feel while remaining water-washable, making it a practical option for patients who need a customized topical preparation.

Patients should only mix medication capsules with BASSAGEL® when those capsules have been specifically prescribed for that purpose. Do not open or mix regular oral medications unless directed by your prescriber or pharmacist.

Ask your healthcare provider whether a BASSAGEL®-based topical treatment may be appropriate for your eczema care plan.

Compounded medications are not FDA-approved and are not reviewed by FDA for safety or efficacy.



https://www.msn.com/en-in/health/health-news/from-itching-to-rash-understanding-the-early-signs-of-eczema-in-summer/ar-AA24fgFq

www.bassagel.com

BASSAGEL™: Advanced Water-Washable Moisturizing Ointment BASSAGEL™ is a water-washable, pharmacist-designed moisturizing ointment used for dry skin, wound care, tattoo aftercare, diaper rash, acne, and more. Gentle, versatile, and easy to remove.

New ribosome research is giving tetracyclines a fresh spotlight.

A newly reported study highlighted by Phys.org shows that tetracyclines may work through dual-site ribosome targeting—not only at the classic mRNA decoding center, but also at the nascent peptide exit tunnel, a second bacterial ribosome site that may help explain the power and selectivity of this antibiotic class.

That matters for topical innovation, too.

When prescribed and compounded appropriately, tetracycline + BASSAGEL® may offer a practical topical delivery approach: BASSAGEL® is water-washable, helps keep medication in contact with the targeted area, and can be removed with water - supporting ease of use in skin and wound-care settings.

In laboratory testing from the University of Houston Microbiology Research Labs, tetracycline 500 mg mixed with BASSAGEL™ was evaluated in a model mimicking a bandaged wound and showed significant reductions across all gram-negative and most gram-positive bacterial species tested. Check out www.bassagel.com/technical-reports to learn more!

Mechanism + delivery = a smarter conversation about localized antimicrobial care.

Read the research spotlight here:

https://phys.org/news/2026-05-ribosome-site-tetracyclines.html

Compounded medications are not reviewed by FDA for safety or efficacy.

Kingdom Investment Holdings

Second ribosome binding site helps explain how tetracyclines work For decades, doctors have widely used tetracyclines for conditions ranging from acne to tick-borne illnesses. Using high-resolution imaging technology, researchers in the laboratory of Christopher Bunick, MD, Ph.D., associate professor of dermatology at Yale School of Medicine (YSM), captured a neve...

Compounding Spotlight: Flucytosine 2% / Clotrimazole 1% in BASSAGEL.

For prescribers and pharmacy colleagues considering patient-specific topical formulations, this preparation stands out for both composition and base selection. It combines two antifungal agents in a base that offers petrolatum-like staying power with water-washable convenience, along with a 180-day BUD.

It is a practical example of formulation design focused on usability, flexibility, and customized care.

Any healthcare provider who wants to see the formula, supportive information, monograph, and the like, reach out via www.bassagel.com.


Bassagel Kingdom Investment Holdings